Eli Lilly & Co. (LLY)

982.22 -15.37 (-1.54%) USD  |  NYSE  |  Dec 09, 16:00
983.91 +1.69 (+0.17%) Pre-Market: 07:29
More

Eli Lilly Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Adverum Biotechnologies, Inc. Upgrade
Viking Therapeutics, Inc. --
Moderna, Inc. Upgrade